Nerinetide clinical trials
Also written NA-1.
How each study uses nerinetide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
5 studies that test it; most in 2015 (2)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
NoNO Inc. (5)
Studies
Open first, then newest update. How each study uses nerinetide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding ThrombolysisCompletedPhase 3NoNO Inc.NCT04462536Written as NerinetideHow we know
- Field Randomization of Nerinetide (NA-1) Therapy in Early RespondersCompletedPhase 3NoNO Inc.NCT02315443Written as Nerinetide (NA-1)How we know
- Safety and Efficacy of Nerinetide (NA-1) in Subjects Undergoing Endovascular Thrombectomy for StrokeCompletedPhase 3NoNO Inc.NCT02930018Written as Nerinetide (NA-1), 2.6 mg/kgHow we know
- Safety and Efficacy Study of a Single Dose of NA-1 in Patients Undergoing Endovascular Repair of Ruptured AneurysmsWithdrawnPhase 2NoNO Inc.NCT02056574Written as NA-1How we know
- Evaluating Neuroprotection in Aneurysm Coiling TherapyCompletedPhase 2NoNO Inc.NCT00728182Written as NA-1How we know
Codes
What other systems call nerinetide · ClinicalTrials.gg INT002124
- MeSH (NLM) C000731677nerinetideOne source NLM
- UNII (FDA) D45TI2TWMANERINETIDEConfirmed FDA, NLM, Wikidata
- Wikidata Q106713417nerinetideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C170212NerinetideOne source FDA
- DrugBank DB12595One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000731677 | nerinetide | One source NLM |
| UNII (FDA) | D45TI2TWMA | NERINETIDE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q106713417 | nerinetide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C170212 | Nerinetide | One source FDA |
| DrugBank | DB12595 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.